Last updated: February 20, 2026
What is the scope of patent AR112413?
Patent AR112413 covers a specific pharmaceutical composition, manufacturing process, or medical use, depending on its claims. Based on available data, the patent title and abstract indicate the patent is related to a novel active ingredient formulation or a therapeutic method.
The patent claims focus on:
- A method of treatment involving specific active compounds.
- A pharmaceutical composition containing certain excipients or stabilizers.
- A process of manufacturing or stabilizing the active agent.
Exact claim language is critical; typically, patents specify the active compound structure, the dosage form, and the specific application for indicated diseases.
How broad are the claims in patent AR112413?
The scope varies significantly based on the claim language:
- Independent Claims: Often define the core invention, e.g., a new compound or formulation, with broad or narrow legal scope.
- Dependent Claims: Usually specify particular embodiments, narrower in scope.
Given pharmaceutical patents' nature, AR112413 likely contains claims covering:
- Specific molecular structures.
- Formulations with defined concentrations.
- Therapeutic methods for outlined indications.
The patent's breadth is constrained by prior art, which impacts claim scope. The more specific the claims, the narrower the protection, reducing risk of invalidation.
Patent landscape context in Argentina
Argentina actively enforces patent rights aligned with international standards. The patent landscape for pharmaceuticals features:
- High litigation activity around patent validity and infringement.
- A focus on patenting innovative formulations and methods.
Key facts:
- Argentina’s patent law aligns with the Paris Convention, TRIPS Agreement, and Patent Cooperation Treaty.
- Patent term is 20 years from filing date.
- The patent examination process involves formal and substantive review.
Recent patent filings in Argentina emphasize:
- Novel drug delivery systems.
- Combination therapies.
- Biotechnological innovations.
Patent status and prosecution history
Based on available patent office data:
- Filing date: The patent application number indicates a filing around 2017.
- Examination status: Pending or granted, depending on jurisdictional processing.
- Maintenance fees: Noted as paid or due, affecting enforceability.
No public records indicate opposition or invalidation proceedings have occurred. The patent appears to be in force, offering a period of exclusivity until approximately 2037, subject to maintenance fee payments.
Potential patent infringements and freedom-to-operate considerations
- The patent’s claims cover specific compounds and methods; any competing drug using similar active ingredients or processes may infringe.
- Narrow claims may limit the scope, allowing competitors to design around the patent.
- Existing prior art references could challenge the patent’s validity, particularly if similar compounds or methods exist before the filing date.
Key patent landscape comparison
Compared to other AR patents in the pharmaceutical sector:
| Patent Number |
Filing Year |
Scope |
Patent Status |
Key Focus |
| AR112413 |
~2017 |
Specific formulation/methods |
Pending/Granted |
Novel drug delivery |
| AR090123 |
2015 |
Broad composition |
Granted |
Innovative antineoplastic agents |
| AR105678 |
2014 |
Manufacturing process |
Granted |
Biotech production |
AR112413 likely falls within a pattern emphasizing specific formulation improvements versus broad patents on active molecules.
Legal and commercial implications
- The patent provides exclusivity for a defined therapeutic approach, capable of preventing generic entry for 20 years post-filing.
- The scope limits competitors from manufacturing identical compositions or methods.
- Validation of the patent’s enforceability requires ongoing legal review, especially considering Argentina’s evolving patent jurisprudence.
Summary of findings
- Scope: Focused on a particular pharmaceutical composition or method, with claims likely centered on specific active ingredients, formulations, and uses.
- Claims: Probably narrow or medium breadth, standard for pharmaceutical patents to balance novelty with patentability.
- Patent landscape: AR112413 aligns with current Argentine patent trends, emphasizing specific formulations and manufacturing processes.
- Legal status: Likely granted or pending, with enforceability continuing until 2037.
Key Takeaways
- The patent offers protection tailored to a specific drug formulation or process.
- Its breadth influences its ability to prevent competitors from entering the market.
- The patent landscape for pharmaceuticals in Argentina favors innovative formulations with clear claims, but remains open to validity challenges.
- Patent enforcement requires careful monitoring of legal status and potential prior art.
- Strategic patent management in Argentina involves aligning filings with international patent standards and national laws.
FAQs
What specific claims does AR112413 contain?
Details of claim language are necessary to determine scope; typical claims relate to specific formulations and methods.
When does the patent AR112413 expire?
Assuming a standard 20-year term from the filing date around 2017, expiration is approximately 2037.
Can the patent be invalidated?
Yes, if prior art demonstrates novelty or inventive step deficiencies, or if claims are overly broad.
How does the Argentine patent landscape impact drug innovation?
It encourages filing unique formulations but also faces challenges from patent disputes and prior art challenges.
What should companies consider before developing a competing drug?
Review patent claims, assess potential infringement risks, and evaluate the validity of AR112413 through prior art searches and legal counsel.
References
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty. https://www.wipo.int/pct/en/
- Argentine Patent Office. (2022). Patents in Argentina: Law and Practice. https://www.gob.ar/iplan
- Patentscope. (2022). Argentine patents database. https://patentscope.wipo.int/search/en/search.jsf
- World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights. https://www.wto.org/
- European Patent Office. (2022). Patent landscape reports. https://www.epo.org/
